Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 294 of 6351
-
Implantable brain device aims to tame Drug-Resistant seizures
Disease control Not yet recruitingThe goal of this clinical trial is to demonstrate the safety and effectiveness of focal cortex stimulation with the EASEE(R) System in a large cohort of subjects with medically refractory focal epilepsy. The main questions it aims to answer are: 1. Is the percentage reduction of…
Sponsor: Precisis US, Inc. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can we decode pancreatic cancer's resistance to chemotherapy?
Knowledge-focused Not yet recruitingAdvanced PDAC patients undergo polychemotherapy, yet responses are highly variable. Transcriptome signatures are emerging as key predictors of treatment response. However, PDAC adapts across sites (primary vs. metastases) and evolves under treatment pressure (pre- vs. post-chemot…
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
New triple combo targets tough lung cancer liver spread
Disease control Not yet recruitingThis is clinical trial evaluating the safety and efficacy of radiotherapy combined with immunotherapy and chemotherapy in patients with extensive-stage small-cell lung cancer (ES-SCLC) and liver metastases.
Phase 2 • Sponsor: Sichuan University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Emergency room care plus Follow-Up: a new strategy to tame severe high blood pressure?
Disease control Not yet recruitingEDIT-SBP is a pragmatic, randomized clinical trial evaluating whether an emergency department (ED)-initiated team-based care program improves blood pressure control among adults discharged from the ED after severe hypertension without hypertensive emergency. Participants will be …
Sponsor: Henry Ford Health System • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Mushrooms and a repurposed antidepressant: a new recipe for weight loss?
Disease control Not yet recruitingThe increasing prevalence of obesity, its serious health consequences, and the substantial economic burden on healthcare systems underscore a pressing need for effective, long-term prevention strategies that can be implemented in primary care. Emerging evidence suggests that comb…
Phase 3 • Sponsor: Uppsala University • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Gut bacteria capsules may stop liver-related brain fog in veterans
Prevention Not yet recruitingThe goal of this clinical trial is to find out whether changing the microbes in the bowels of Veterans with cirrhosis and hepatic encephalopathy (a condition that affects the brain as a result of liver problems) using capsules made from microbes from healthy people can prevent fu…
Phase 2 • Sponsor: VA Office of Research and Development • Aim: Prevention
Last updated Jun 27, 2026 12:07 UTC
-
Experimental drug aims to improve breathing in lung sarcoidosis
Disease control Not yet recruitingA study of XTMAB-16 in patients with pulmonary sarcoidosis
Phase 2 • Sponsor: Xentria, Inc. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New drug could unblock Crohn's-Related bowel narrowing without surgery
Disease control Recruiting nowMany patients with Crohn's disease (CD) develop fibrotic narrowing (strictures) in their bowel, causing obstructive symptoms such as abdominal pain, cramping, or vomiting after meals. Because of these symptoms, patients often require bowel resection surgery. The objective of this…
Phase 2 • Sponsor: Agomab Spain S.L.U. • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Can gene therapy zolgensma safely improve motor skills in SMA?
Knowledge-focused Not yet recruitingThis study aims to assess the safety and effectiveness of onasemnogene abeparvovec intrathecal injection in spinal muscular atrophy (SMA) patients in clinical practice in Japan. This is a non-interventional study and does not impose a therapy protocol, diagnostic/therapeutic pro…
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
Could a new oral ketamine capsule ease bipolar depression when other treatments fail?
Symptom relief Not yet recruitingThis study is testing a new oral ketamine treatment called KET-AD in adults with treatment-resistant bipolar depression (TRBD). The study will look at how safe and tolerable the treatment is, and whether it may help improve symptoms of depression when used together with a partici…
Phase 2 • Sponsor: Neurocentrx Pharma Pty Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Can exercise counteract Cancer's muscle wasting?
Disease control Not yet recruitingThis study investigates the role of a structured physical therapy (PT) program in managing cancer-induced cachexia (CIC) by targeting muscle-bone crosstalk. Cancer-induced cachexia leads to severe muscle wasting, systemic inflammation, and functional decline, which often limits t…
Sponsor: Pharos University in Alexandria • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a single inhaled dose shorten the flu?
Disease control Not yet recruitingThis multicenter, randomized, double-blind, placebo-controlled, parallel-group Phase 3 study will evaluate the efficacy and safety of peramivir inhalation solution in adults with uncomplicated influenza. Approximately 600 participants aged 18 to 64 years with laboratory-confirmed…
Phase 3 • Sponsor: Capital Medical University • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New hope for kids with tough neuroblastoma: drug combo trial opens
Disease control Not yet recruitingThis phase I/II trial studies the side effects and best dose of iberdomide when given together with chemoimmunotherapy drugs and to see how well it works in treating patients with neuroblastoma that has come back after a period of improvement (relapsed), that does not respond to …
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 10, 2026 02:00 UTC
-
Can an inhaled powder calm the painful Cold-Finger attacks of scleroderma?
Symptom relief Not yet recruitingSystemic sclerosis (SSc) is a rare autoimmune disease in which many patients experience Raynaud's phenomenon (RP) - painful episodes where commonly fingers or toes change color and become painful, numb, or tingly, usually triggered by cold or stress. This open-label study is test…
Phase 2 • Sponsor: Liquidia Technologies, Inc. • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Experimental CAR-T therapy targets tough T-Cell cancers
Disease control Recruiting nowOverall Introduction This single-arm, open-label clinical trial aims to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of CXCR4-enabled CCR9 chimeric antigen receptor T-cell injection (CXCR4 CCR9 CAR-T) in patients with relapsed or refractory T-lymphobl…
Phase 1 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can freezing or heating nerves end Athletes' chronic ankle pain?
Symptom relief Not yet recruitingLigamentous injuries of the ankle are common among athletes. Inversion injuries of the ankle account for 40% of all athletic injuries. The anterior talofibular ligament (ATFL) and the calcaneofibular ligament (CFL) are sequentially the most commonly injured ligaments when a plant…
Sponsor: Assiut University • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
Could a vaccine stop Alzheimer's before it starts?
Vaccine Not yet recruitingThis Phase 1 study will test the safety and immune response of the investigational vaccine DUVAX in healthy adults. Participants will be randomly assigned to receive either DUVAX or placebo by intramuscular injection. The study will evaluate how well the vaccine is tolerated and …
Phase 1 • Sponsor: Nuravax, Inc. • Aim: Vaccine
Last updated Aug 26, 2026 00:00 UTC
-
AI as a coach for caregivers: a new test of support and strength
Symptom relief Not yet recruitingPrimary caregivers of palliative care patients assume responsibility for meeting the patient's needs, monitoring symptoms, maintaining care practices, and managing changing needs. Increased responsibilities, uncertainty, and lack of information and support can negatively impact c…
Sponsor: Kastamonu University • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
Fiber gummies: a tasty new weapon against obesity?
Disease control Not yet recruitingOverweight and obesity are common conditions that increase the risk of metabolic and cardiovascular diseases. Polydextrose is a type of dietary fiber that may help increase feelings of fullness by influencing natural hormones involved in appetite regulation. It may also improve p…
Sponsor: Nutris We Care About You S.L. • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Could ketamine boost recovery for critically ill patients on ventilators?
Symptom relief Not yet recruitingInvasive mechanical ventilation of critically ill patients in the intensive care unit (ICU) is associated with significant morbidity and mortality, as well as a severe prognosis in survivors, in terms of functional, psychological, and cognitive sequelae. During the initial phase,…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC